HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Abnormal tissue oxygenation and cardiovascular changes in endotoxemia.

Abstract
Experimental sepsis induces disturbances in microcirculatory flow and nutrient exchange that may result in impaired tissue oxygenation. Volume resuscitation is a principal clinical intervention in patients with sepsis. Nitric oxide (NO) has been implicated in the pathophysiology of endotoxemia, but few data exist concerning the effects of either NO synthase inhibition (NOSi) or volume resuscitation on microvascular regulation and tissue oxygenation. Amperometric measurements were made of skeletal muscle (tissue) oxygen tension (PtO2) and its response to changes in fraction of inspired oxygen (FIO2) in rats rendered endotoxemic. Simultaneous measurements were made of systemic hemodynamic indices and arterial blood gas tensions. At normal PaO2, PtO2 in endotoxemic animals was significantly lower than in control animals, with marked attenuation of the response to increasing FIO2. These changes were associated with significant metabolic acidemia. In volume-resuscitated endotoxemic rats, PtO2 and blood pH were unchanged. A significant reduction in the PtO2 response to hyperoxia was observed in animals treated with the NOS inhibitor NG-nitro-L-arginine methyl ester (L-NAME), an effect not reversed by fluid resuscitation. These data suggest that significant tissue hypoxia and abnormal microvascular control occur in endotoxemia. Volume resuscitation can reverse the changes in PtO2, whereas nitric oxide synthase (NOS) inhibition has deleterious effects on muscle PtO2 in both control and endotoxemic animals.
AuthorsP B Anning, M Sair, C P Winlove, T W Evans
JournalAmerican journal of respiratory and critical care medicine (Am J Respir Crit Care Med) Vol. 159 Issue 6 Pg. 1710-5 (Jun 1999) ISSN: 1073-449X [Print] United States
PMID10351908 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Enzyme Inhibitors
  • Oxygen
  • NG-Nitroarginine Methyl Ester
Topics
  • Animals
  • Cardiovascular System (physiopathology)
  • Endotoxemia (physiopathology, therapy)
  • Enzyme Inhibitors (therapeutic use)
  • Fluid Therapy
  • Hemodynamics (physiology)
  • Male
  • Muscle, Skeletal (metabolism)
  • NG-Nitroarginine Methyl Ester (therapeutic use)
  • Oxygen (metabolism)
  • Oxygen Consumption (physiology)
  • Partial Pressure
  • Pulmonary Gas Exchange (physiology)
  • Rats
  • Rats, Wistar
  • Resuscitation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: